Skip to main content

Table 9 Sensitivity to selected parameters of the cost-effectiveness ratio and the incremental cost-effectiveness ratio (ICER) for treating malaria, diarrhoea and suspected pneumonia in children under-five under iCCM and CHPS in the Volta Region

From: Cost-effectiveness analysis of the national implementation of integrated community case management and community-based health planning and services in Ghana for the treatment of malaria, diarrhoea and pneumonia

Indicators

iCCM

CHPS

iCCM

CHPS

iCCM

CHPS

Average facility cost

More costly facility

Less costly facility

Costs per 100 children (ACT or quinine)

119.0

182.3

141.1

234.0

97.0

130.6

Number treated according to protocol (prompt ACT or quinine)

21

15

21

15

21

15

Incremental cost-effectiveness ratio (prompt ACT or quinine)

iCCM dominates

iCCM dominates

iCCM dominates

Cost per 100 children (ORS and zinc)

9.8

47.5

11.2

64.4

8.3

30.7

Number treated according to protocol (ORS and zinc)

54

43

54

43

54

43

Incremental cost-effectiveness ratio (ORS and zinc)

ICCM dominates

iCCM dominates

iCCM dominates

Costs per 100 children (amoxicillin)

19.9

122.1

20.5

168.9

19.1

75.6

Number treated according to protocol (amoxicillin)

72

72

72

72

72

72

Incremental cost-effectiveness ratio (amoxicillin)

iCCM less costly/same effectiveness

iCCM less costly/same effectiveness

iCCM less costly/same effectiveness

 

3% discount rate

5% discount rate

7% discount rate

Costs per 100 children (ACT or quinine)

119.04

182.30

121.20

187.66

127.68

202.60

Number treated according to protocol (prompt ACT or quinine)

21

15

21

15

21

15

Incremental cost-effectiveness ratio (prompt ACT or quinine)

iCCM dominates

iCCM dominates

iCCM dominates

Cost per 100 children (ORS and zinc)

9.78

47.54

9.78

48.46

9.89

49.84

Number treated according to protocol (ORS and zinc)

54

43

54

43

54

43

Incremental cost-effectiveness ratio (ORS and zinc)

iCCM dominates

iCCM dominates

iCCM dominates

Costs per 100 children (amoxicillin)

19.87

122.13

19.87

124.59

19.87

127.87

Number treated according to protocol (amoxicillin)

72

72

72

72

72

72

Incremental cost-effectiveness ratio (amoxicillin)

iCCM less costly/same effectiveness

iCCM less costly/same effectiveness

iCCM less costly/same effectiveness

 

Average utilization

Higher utilization

Lower utilization

Costs per 100 children (ACT or quinine)

119.04

182.30

110.40

166.21

144.00

226.91

Number treated according to protocol (prompt ACT or quinine)

21

15

21

15

21

15

Incremental cost-effectiveness ratio (prompt ACT or quinine)

iCCM dominates

iCCM dominates

iCCM dominates

Cost per 100 children (ORS and zinc)

9.78

47.54

8.67

43.48

12.78

50.23

Number treated according to protocol (ORS and zinc)

54

43

54

43

54

43

Incremental cost-effectiveness ratio (ORS and zinc)

iCCM dominates

iCCM dominates

iCCM dominates

Costs per 100 children (amoxicillin)

19.87

122.13

14.64

112.13

36.46

128.85

Number treated according to protocol (amoxicillin)

72

72

72

72

72

72

Incremental cost-effectiveness ratio (amoxicillin)

iCCM less costly/same effectiveness

iCCM less costly/same effectiveness

iCCM less costly/same effectiveness

 

Average effectiveness

Higher effectiveness

Lower effectiveness

Costs per 100 children (ACT or quinine)

119.04

182.30

111.86

178.28

88.40

186.13

Number treated according to protocol (prompt ACT or quinine)

21

15

31

15

11

15

Incremental cost-effectiveness ratio (prompt ACT or quinine)

iCCM dominates

iCCM dominates

iCCM is less costly and less effective

Cost per 100 children (ORS and zinc)

9.78

47.54

6.82

47.15

14.40

47.87

Number treated according to protocol (ORS and zinc)

54

43

59

43

49

43

Incremental cost-effectiveness ratio (ORS or zinc)

iCCM dominates

iCCM dominates

iCCM dominates

Costs per 100 children (amoxicillin)

19.87

122.13

19.55

121.97

19.97

122.30

Number treated according to protocol (amoxicillin)

72

72

80

72

65

72

Incremental cost-effectiveness ratio (amoxicillin)

iCCM dominates

iCCM dominates

iCCM is less costly and less effective